Mirae Asset Healthcare Fund - Direct Plan - Growth

  • Scheme Category:  
  • Equity Scheme >  
NAV: ₹ 52.204 ↑ 0.91%
[as on 3 November, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of Mirae Asset Healthcare Fund - Direct Plan - Growth and its peers as on 3 November, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Mirae Asset Healthcare Fund - Direct Plan - Growth 22.11% 0.91% 3.6% 2.07% 1.08% 19.08% 23.9% 16.62% 25.09%-
HDFC Defence Fund - Growth Option - Direct Plan 23.69% 1.8% 1.79% -1.78% -2.98% 15.5% 35.15%---
HDFC Technology Fund - Growth Option - Direct Plan -10.51% 0.72% 0.1% 11.14% 0.08% -8.02% 9.36%---
Nippon India Consumption Fund - Direct Plan Growth Plan - Growth Option -6.25% 2.01% 3.72% 3% -7.89% -8.33% 9.16% 11.15% 16.27% 12.99%
Nippon India Japan Equity Fund- Direct Plan- Growth Plan- Growth Option 21.01% -1.49% -1.39% -5.09% -1.06% 21.45% 21.8% 9.8% 11.31% 10.91%
Nippon India US Equity Opportunities Fund- Direct Plan- Growth Plan- Growth Option 8.63% -0.45% -2.38% -3.41% -0.53% 11.45% 19.02% 11.01% 15.06% 16.37%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns--- 8.32% 77.37% 27.95% -10.87% 36.86% 41.36% -2.65%

Discrete returns (monthly)

MonthJan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
Returns -5.19% 7.4% -3.5% 6.96% 3.31% 5.37% 5.1% 2.11% -2.04% 1.15%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 15.73% 9.52%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.67% 0.01% (Arbitrage: 0.00%) 0.00% 0.00% 0.32%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.90%
Divi's Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology9.91%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology7.06%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services5.91%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology5.24%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology4.99%
Dr. Reddy's Laboratories Ltd.DRREDDY (INE089A01031)Pharmaceuticals & Biotechnology3.94%
Aurobindo Pharma Ltd.AUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.81%
IPCA Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology3.43%
Fortis Healthcare Ltd.FORTIS (INE061F01013)Healthcare Services3.40%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology3.39%
Sai Life Sciences Ltd.SAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.30%
Krishna Institute of Medical Sciences Ltd.KIMS (INE967H01025)Healthcare Services3.16%
Aster DM Quality Care Ltd.ASTERDM (INE914M01019)Healthcare Services3.01%
Onesource Specialty Pharma Ltd.ONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology2.96%
Dr. Lal Path labs Ltd.LALPATHLAB (INE600L01024)Healthcare Services2.77%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology2.71%
Max Healthcare Institute Ltd.MAXHEALTH (INE027H01010)Healthcare Services2.58%
Eris Lifesciences Ltd.ERIS (INE406M01024)Pharmaceuticals & Biotechnology2.55%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology2.44%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology2.40%
Biocon Ltd.BIOCON (INE376G01013)Pharmaceuticals & Biotechnology2.13%
Mankind Pharma Ltd.MANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.13%
Molbio Diagnostics Ltd. (INE869T01028)Healthcare Equipment & Supplies1.44%
Anthem Biosciences Ltd.ANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology1.13%
Symbiotec Pharmalab Ltd A** (INE899I01028)Pharmaceuticals & Biotechnology0.98%
Narayana Hrudayalaya Ltd.NH (INE410P01011)Healthcare Services0.91%
Neogen Chemicals Ltd.NEOGEN (INE136S01016)Chemicals & Petrochemicals0.64%
Deepak Nitrite Ltd.DEEPAKNTR (INE288B01029)Chemicals & Petrochemicals0.45%

Debt

NameIsinRatingWeight %Yield
Mirae Asset Liquid Fund-Direct Plan-GrowthINF769K01CM10.01%%
Portfolio data is as on date 31 August, 2026

NAV history

Mirae Asset Healthcare Fund - Direct Plan - Growth - 30 days NAV (Net asset value) history

DateNAV% change
3 November, 202652.204 0.91%
2 November, 202651.732 0.14%
30 October, 202651.660 1.07%
29 October, 202651.111 0.46%
28 October, 202650.875 0.96%
27 October, 202650.390 2.5%
26 October, 202649.163 1.81%
23 October, 202648.288 -1.09%
22 October, 202648.822 -0.17%
21 October, 202648.904 -0.58%
19 October, 202649.189 -1.08%
16 October, 202649.728 -0.21%
15 October, 202649.834 -0.14%
14 October, 202649.906 -1.04%
13 October, 202650.432 0.05%
12 October, 202650.406 0.01%
9 October, 202650.402 1.01%
8 October, 202649.896 -2.25%
7 October, 202651.044 -0.21%
6 October, 202651.152 1.12%
5 October, 202650.584 -1.09%
1 October, 202651.144 0.17%
30 September, 202651.056 -2.2%
29 September, 202652.206 0.46%
28 September, 202651.965 -0.99%
25 September, 202652.485 -0.55%
24 September, 202652.777 -0.66%
23 September, 202653.127 0.85%
22 September, 202652.680 -0.45%
21 September, 202652.919

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The latest NAV of Mirae Asset Healthcare Fund - Direct Plan - Growth is 52.204 as on 3 November, 2026.
  • What are YTD (year to date) returns of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The YTD (year to date) returns of Mirae Asset Healthcare Fund - Direct Plan - Growth are 22.11% as on 3 November, 2026.
  • What are 1 year returns of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The 1 year returns of Mirae Asset Healthcare Fund - Direct Plan - Growth are 19.08% as on 3 November, 2026.
  • What are 3 year CAGR returns of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund - Direct Plan - Growth are 23.9% as on 3 November, 2026.
  • What are 5 year CAGR returns of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund - Direct Plan - Growth are 16.62% as on 3 November, 2026.
  • What are top 10 holdings of Mirae Asset Healthcare Fund - Direct Plan - Growth?
    Top 10 holdings of Mirae Asset Healthcare Fund - Direct Plan - Growth are:
    • Sun Pharmaceutical Industries Ltd.
    • Divi's Laboratories Ltd.
    • Torrent Pharmaceuticals Ltd.
    • Apollo Hospitals Enterprise Ltd.
    • Laurus Labs Ltd.
    • Glenmark Pharmaceuticals Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Aurobindo Pharma Ltd.
    • IPCA Laboratories Ltd.
    • Fortis Healthcare Ltd.
    • Alkem Laboratories Ltd.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Mirae Asset Healthcare Fund - Direct Plan - Growth?
    Mirae Asset Healthcare Fund - Direct Plan - Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.